#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Fabry's disease Cholestatic pruritus Synovial sarcoma Bronchopulmonary aspergillosis Encephalitis autoimmune Human papilloma virus immunisation Metachromatic leukodystrophy Optic glioma Medulloblastoma recurrent Hereditary optic atrophy Juvenile psoriatic arthritis Inclusion body myositis Malignant oligodendroglioma Autoimmune demyelinating disease Pleomorphic leiomyosarcoma More trials…

    Learn about Rare Diseases

    Hepatoblastoma – Diagnostics Glomerulonephritis rapidly progressive – Diagnostics Adrenocortical carcinoma – Diagnostics MELAS syndrome – Diagnostics Hereditary angioedema – Life with Disease Indolent systemic mastocytosis – Treatment Thrombotic thrombocytopenic purpura – Treatment Hepatic angiosarcoma – Treatment Ewing’s sarcoma – Life with Disease Ewing’s sarcoma recurrent – Basic Information More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ceralasertib Fluorouracil Star-0215 SAR445399 Sodium Phosphate Dodecahydrate Methotrexate Disodium AB521 Evg321 Azd4831 Human Coagulation Factor Ii Tozinameran Vamorolone Antipsychotics Tyra-300-B01 Apadamtase Alfa Adct-402 GSKVX000000039711 Alogliptin ZINC CHLORIDE Macrogol 3350 More therapies…

    Learn about Your Condition

    Hepatic adenoma Meningorrhagia Malignant neoplasm of choroid Dry eye White matter lesion Myotonic dystrophy Post procedural swelling Caesarean section Renal injury Lymphangioma Erythema migrans Hyperparathyroidism primary ROHHAD syndrome Spinal osteoarthritis Neutropenia More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Pathological Conditions, Signs and Symptoms

  • Study on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Sodium Chloride
    Denmark

  • Study on Duloxetine and Benztropine Mesylate for Patients with Severe Functional Somatic Disorder

    Recruiting

    3 1 1
    Investigated Diseases:
    • Somatic symptom disorder
    Investigated Drugs:
    • Benztropine Mesylate
    • Duloxetine
    Denmark

  • Study of sodium zirconium cyclosilicate compared to standard care for managing high blood potassium levels in patients with chronic kidney disease

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Hyperkalaemia
    • Chronic kidney disease
    Investigated Drugs:
    • Sodium Zirconium Cyclosilicate
    Spain

  • Study on Using Exenatide PET/CT Imaging for Detecting Paragangliomas in Patients

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Paraganglion neoplasm
    Investigated Drugs:
    • Exenatide
    The Netherlands

  • Study on the Safety and Effectiveness of Human Plasma Proteins and Glutathione for Patients with Decompensated Cirrhosis

    Recruiting

    2 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Glutathione (Reduced), Sodium Salt
    • Human Plasma Proteins With Not Less Than 96% Albumin
    Italy

  • Study of dexpanthenol mouth rinse for preventing radiation-induced oral mucositis in patients receiving radiotherapy

    Recruiting

    3 1 1
    Investigated Drugs:
    • Dexpanthenol
    Germany
Previous Page
1 … 5 6 7 8 9 … 21
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!